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ABSTRACT 
It is widely accepted that the cell of origin of breast cancer is the adult mammary epithelial 
stem cell, however demonstrating the presence and location of tissue stem cells in the 
human breast has proved difficult. Furthermore, we do not know the clonal architecture of 
the normal and premalignant mammary epithelium or its cellular hierarchy. Here we use 
deficiency in the mitochondrial enzyme cytochrome c oxidase (CCO), typically caused by 
somatic mutations in the mitochondrial genome, as a means to perform lineage tracing in 
the human mammary epithelium. PCR sequencing of laser-capture microdissected cells in 
combination with immunohistochemistry for markers of lineage differentiation was 
performed to determine the clonal nature of the mammary epithelium.  We have shown 
that in the normal human breast, clonal expansions (defined here by areas of CCO-
deficiency) are typically uncommon and of limited size, but can occur at any site within the 
adult mammary epithelium. The presence of a stem cell population was shown by 
demonstrating multilineage differentiation within CCO-deficient areas. Interestingly, we 
observed infrequent CCO-deficiency that was restricted to luminal cells, suggesting that 
niche succession and by inference stem cell location, is located within the luminal layer.  
CCO-deficient areas appeared large within areas of ductal carcinoma in situ, suggesting 
that the rate of clonal expansion was altered in the premalignant lesion.  
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INTRODUCTION 
The stem cell hierarchy of the human mammary epithelium has been the subject of much 
debate.  Previous studies suggest that stem cells in the normal human breast are located 
within the luminal epithelial layer and also give rise to the myoepithelial cells [1,2]. 
However, in vitro studies show the possible existence of progenitor cells that may 
differentiate into luminal cells from either the myoepithelial or luminal lineages, or indeed 
from both [1-7].  There is further evidence for a subset of luminal cells that express 
cytokeratin 5 (CK5), and can give rise to both luminal and myoepithelial lineages. This 
subset may also represent a stem cell population and potentially act as cells of origin for 
breast cancer [8-10]. In addition, a recent study in human tissue combining a novel 3D 
fractal model approach with a theoretical model and with the expression of the putative 
stem cell marker high aldehyde dehydrogenase (ALDH1A1) has suggested that during 
morphogenesis of the mammary gland the intralobular branching ducts are the site of 
cellular expansion and growth. This would indicate that this site may be the location of 
stem cells within the adult breast [11].  However, a novel analysis of multicolour lineage 
tracing at saturation during during pubertal development of the mouse mammary gland 
rules out the presence and role of multipotent stem cells during adult tissue remodelling 
[12].  
 
Consequently, the location and characterisation of stem cells in the human breast is still 
unknown. The major hindrance to our understanding of the location of the human breast 
stem cell has been a lack of markers that definitively demonstrate multilineage 
differentiation and clonal expansion within tissue sections. To date no human lineage 
tracing studies have been performed to show this. To determine the location of stem cells 
within the human mammary epithelium we have used a lineage tracing technique where 
mitochondrial DNA (mtDNA) mutations act as a marker of clonal expansion [13]. Mutant 
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cells are identified by the deficiency of the mitochondrial enzyme cytochrome c oxidase 
(CCO). Serial sections subjected to immunohistochemistry for lineage-specific markers, in 
combination with sequencing of the mitochondrial genome from distinct microdissected 
mammary epithelial cells, demonstrated multilineage differentiation which is the gold 
standard for stem cell identification [14]. MtDNA mutations accumulate within normal 
tissue stem cells and increase in frequency with age, reaching homoplasmy or detectable 
levels of heteroplasmy in mid to late life [15]. We have shown previously that this method 
allows identification of the stem cell niche in the human stomach [16], small bowel [17] and 
in the normal and premalignant prostate [18]. Furthermore, somatic mtDNA mutations are 
neutral, conferring no selective advantage or disadvantage permitting analysis of steady 
state clonal competition within the normal human mammary gland [19]. 
 
Here we investigate in detail the clonal architecture of the normal and premalignant 
epithelium in situ in the human mammary gland. Stem cells have been long considered the 
likely origin of cancer [20,21]: therefore, our findings may shine light not only on 
homeostasis of the normal mammary gland, but also on their contribution to the origin of 
premalignant lesions and invasive cancer. Here, we show that clonal expansions 
demonstrating multilineage differentiation from a single stem cell can occur in any area of 
the normal human breast epithelium.  
 
Ductal carcinoma in situ (DCIS) is considered unanimously to be a precursor of invasive 
ductal cancer (IDC), because several studies have found a link between genetic 
alterations which occur in the premalignant lesion and are maintained in the invasive 
lesion [22-25]. 
However, the human DCIS stem cell has not been identified, nor has the extent to which a 
stem cells progeny can expand through the breast. Here we show lineage tracing within 
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human DCIS that may provide an insight into its cell of origin, a mode of expansion within 
the human breast and a potential understanding of the neoplastic process.  
 
MATERIALS AND METHODS 
Tissue  
Fresh frozen and formalin-fixed paraffin-embedded (FFPE) clinical samples from patients 
undergoing breast surgery between 2004 and 2009 at Barts Health NHS Trust, London, 
UK were studied following patient consent and approval from the local research ethics 
committee and deposited in the Breast Cancer Now tissue bank (formerly Breast Cancer 
Campaign tissue bank, ref: 10/H0308/49). Fresh-frozen DCIS clinical samples were also 
obtained from the Erasmus Medical Center Rotterdam, The Netherlands (MEC 02.953), 
with the study adhering to the Code of Conduct of the Federation of Medical Scientific 
Societies in The Netherlands; from the Imperial College London Tissue Bank, UK, 
following patient consent and approval from the local research ethics committee (ref: 
ICHTB HTA, licence: 12275, REC Wales approval: 12/WA/0196) and from the Fondazione 
IRCSS, Istituto Nazionale Tumori, Milano, Italy (ref: INT 199/15). 
 
Enzyme histochemistry 
Frozen sections (16 μm) of breast tissue underwent sequential CCO and succinate 
dehydrogenase (SDH) enzyme histochemistry, as described previously [15]. CCO/SDH 
histochemistry permits the detection of CCO-normal cells (brown) contrasting with CCO-
deficient cells (blue due to SDH activity). In brief, sections were incubated first in 
cytochrome c medium (100 mM cytochrome c, 4 mM diaminobenzidine tetrahydrochloride 
(brown chromogen), 20 μg/ml catalase in 0.2 M phosphate buffer, pH 7.0, all from Sigma 
Aldrich, Poole, UK) for 40 min at 37 °C to allow detection of CCO activity in brown, 
followed by washes in PBS, pH 7.4, for 3 x 5 min then by incubation in SDH medium (130 
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mM sodium succinate, 200 mM phenazine methosulphate, 1 mM sodium azide, 1.5 mM 
nitroblue tetrazolium in 0.2 M phosphate buffer, pH 7.0) for 45 min at 37 °C to allow 
detection of SDH activity with nitroblue tetrazolium (blue chromogen).  Sections were 
allowed to dry in air for microdissection or dehydrated in increasing ethanol concentrations 
followed by clearing in Histoclear (Fisher Scientific, Leicestershire, UK). All images were 
captured using a Pannoramic 250 Flash III scanner and viewed using Pannoramic viewer 
software (3D Histotech, Budapest, Hungary). 
 
Immunohistochemistry 
Five-micron thick FFPE tissue sections were dewaxed and subjected to boiling in 10 mM 
sodium citrate buffer solution, pH 6.0 (Sigma, UK) for 20 min. Endogenous peroxidase 
activity was blocked with 3% hydrogen peroxide solution for 10 min, followed by a serum 
free protein block (Dako, Ely, UK) for 10 min. Sections were incubated for 1 h at room 
temperature with primary antibody mouse anti-human CCO (OxPhos Complex IV subunit I; 
Life Technologies, Paisley, Scotland, UK) at a 1:100 dilution in blocking serum, followed by 
incubation for 40 min at room temperature in biotin conjugated goat anti-mouse IgG 
(1:500, Dako). Sections were then incubated in streptavidin-conjugated HRP (1:500, Dako) 
for 30 min at room temperature. Colour was developed with a DAB Peroxidase (HRP) 
Substrate Kit (Vector laboratories, Peterborough, Cambridgeshire, UK) according to the 
manufacturers’ recommendations and counterstained with haematoxylin, before 
dehydration through alcohol, clearing in xylene and mounting. 
 
Fluorescence immunohistochemistry 
FFPE tissue sections were dewaxed and unmasked as above. Fresh frozen sections were 
fixed in an ice-cold 1:1 acetone-methanol solution for 5 min at room temperature. Sections 
were blocked with serum free protein block (Dako) for 40 min. Sections were then 
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incubated for 1 h at room temperature with primary antibodies: αSMA (1A4, Dako), CK18 
(EPR1626, Abcam, Cambridge, UK), both at a 1:50 dilution in blocking serum and mouse 
anti-CCO (OxPhos Complex IV subunit I; 1D6-E1A8, Life Technologies) at a 1:100 dilution 
in blocking serum, followed by incubation for 40 min at room temperature in Alexa Fluor 
488 conjugated goat anti-mouse IgG or Alexa Fluor 594 conjugated goat anti-rabbit IgG 
(Life Technologies) added at a 1:1500 dilution in blocking serum. Sections were mounted 
in Prolong Gold anti-fade with DAPI (Invitrogen, Carlsbad, CA) and analysed using an 
Axioplan microscope equipped with AxioCam MRc and AxioVision software (Zeiss, 
Munich, Germany). In each analysis, positive and negative controls were available. When 
enzyme histochemistry was combined with IHC on the same section, CCO histochemistry 
was performed as described first, followed by fixation with a 1:1 acetone:methanol solution 
as above. 
 
Extraction of mtDNA from microdissected tissue 
Frozen sections (16 µm thick) were cut onto PALM membrane slides (Zeiss), and air-dried 
at room temperature for 1h then subjected to enzymatic CCO staining as described above. 
Single cells or larger areas of interest from mammary ducts and terminal duct lobular units 
(TDLUs) were then microdissected on a PALM laser capture system (Zeiss) at a uniform 
laser power and cutting width into PALM-specific 0.5 ml tubes. Stromal tissue was used as 
a control from each section. DNA was extracted using QIAamp DNA Micro kits (Qiagen, 
Hilden, Germany) according to the manufacturer’s protocol.  
 
Sanger sequencing 
A nested PCR protocol producing thirty-six, 500 bp overlapping fragments covering the 
entire mitochondrial genome (mtDNA) was followed as described previously [15]. PCR 
products were treated with ExoSaP-IT (GE Healthcare, Little Chalfont, UK) according to 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
the manufacturer’s protocol and subjected to a Sanger sequencing reaction using Big Dye 
3.1 (Life Technologies) then purified by ethanol precipitation and run on an ABI Prism 
3100 genetic analyzer (Life Technologies). Sequence traces were analyzed using 4Peaks 
software (www.mekentosj.com) together with Clustal W2 software (EMBL-EBI) and 
compared to the revised Cambridge reference sequence [26] and sequences from stromal 
controls and CCO-normal specimens to eliminate polymorphisms from the CCO-deficient 
sequences.  
 
RESULTS 
Visualization of clonal expansions within normal and pre-invasive (DCIS) human 
mammary epithelium  
To determine the presence of putative progenitor/stem cells in the human breast, we first 
performed dual enzyme histochemistry for CCO activity (brown) and succinate 
dehydrogenase (blue, to highlight CCO-deficiency) that has been shown previously to 
highlight clonally-related cells [27]. We detected areas of CCO-deficiency in 9/45 patients 
(20%) normal breast specimens and in 5/54 (9.2%) DCIS patients. CCO-deficiency in the 
normal breast was limited to small epithelial patches. These CCO-deficient patches were 
detected in terminal duct lobular units (TDLUs) (Figure 1A-D) as well as in ducts (Figure 
1E-H). CCO-deficient areas were also detected in areas of DCIS, but were not detected as 
frequently as in the normal breast. However, CCO-deficient areas in DCIS appeared to be 
larger in size, covering either part of, or the entire cross section of the lesion (Figure 1I-J).   
 
To formally demonstrate that patches of CCO-deficient cells represent bona fide clonal 
expansions, multiple CCO-deficient (blue) cells from both normal and DCIS cases were 
non-contact laser-capture microdissected and their entire mtDNA genome sequenced to 
reveal common mutations that would indicate a common cell-of-origin. Figure 2 shows a 
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TLDU that possessed both CCO-deficient and CCO-normal cells (Fig 2A-E). All 
microdissected cells from CCO-deficient areas contained the same mtDNA mutation 
(3127G>A), that was not present in the surrounding CCO-proficient cells, demonstrating a 
clonal expansion (Figure 2F). Clonal expansions were also observed in CCO-deficient 
areas in ducts. Figure 3 shows a classical duct (Figure 2G and 2H) that contained a small 
CCO-deficient area (Figure 2I-K) and each deficient cell harboured a 1609T>C mtDNA 
mutation (Figure 2L). These data suggest that clonal expansions may arise within the 
normal human breast in both ductal and TDLU epithelium. 
 
In DCIS, CCO-deficient areas appeared much larger than in normal breast epithelium: 
entire DCIS ducts were clonal, each area containing a clonal mtDNA mutation. Figure 3A 
shows an H&E stained section of an area of DCIS and Figure 3B shows the same area 
stained for CCO activity. CCO-deficient DCIS ducts (Figure 3Bi & ii) and a CCO-proficient 
duct (Figure 3Biii) were present. Distinct areas microdissected from CCO-deficient duct 
(Figure 3Ci, areas 1 and 2) shared a common 11867_11873insC mutation (identified and 
shown as an insG mutation in the reverse strand sequence, repeated on 3 independent 
microdissected areas) that was not present in the distant CCO-proficient cells (Figures 
3Ciii, area 5). The neighbouring CCO-deficient duct (Figure 3BCi) was not related to this, 
however it was clonal for a heteroplasmic 957 G>A mutation (Figure 3Cii areas, 3 & 4), 
and this was also not present in the surrounding CCO-normal DCIS (Figures 3Ciii area, 5). 
These data suggest that the rate of clonal expansion is higher in neoplastic breast 
epithelium compared to normal breast epithelium and that multiple competing clones are 
capable of arising within the same DCIS lesion. 
 
Clonal populations in normal and neoplastic breast epithelium contain multipotent 
stem cells 
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To investigate whether the clonal CCO−deficient areas contain multipotential stem cells, 
we performed fluorescence immunohistochemistry to determine the expression pattern of 
markers for luminal and myoepithelial cells to seek evidence of multilineage differentiation: 
the gold standard for stem cell identification (14). Figure 4 (A-L) shows CCO-deficient 
epithelial cells in serial sections of normal adult breast co-localized with αSMA-positive 
myoepithelial cells and CK18-positive luminal epithelial cells. This pattern was observed 
both in normal adult breast and DCIS (Figure 4M-P’). While small clusters of fluorescent 
cells were observed close to the myoepithelial layer in all stained sections (CK18, αSMA 
and CCO), they appeared to be autofluorescent blood cells based on morphological 
features and geographical location (H&E in supplementary information, Figure S1). While 
we cannot exclude the possibility that these cells could be myoepithelial cells, the vast 
majority, if not all, myoepithelial cells were CCO-negative.  This indicates that both the 
normal and premalignant mammary epithelium contains multipotent lineages, each 
maintained by a dedicated population of stem cells.  
 
Clones restricted to the luminal layer of normal mammary ducts 
Several studies have argued that mammary stem cells are located in either or both of the 
luminal or myoepithelial layers. A thorough investigation of all CCO-deficient areas within 
our cohort of patients revealed a small subset of normal breast samples (2/45; 4.5%), 
where CCO-deficient patches were restricted to the luminal cell layer (Figure 5), without 
involvement of the underlying CCO-positive myoepithelial layers. We never detected a 
sample in which CCO-deficiency was restricted to the myoepithelial layer, therefore 
suggesting that each clone is derived from a dedicated progenitor cell located within the 
luminal epithelial layer.  
 
DISCUSSION 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Lineage tracing in murine models and in vitro studies have offered significant insight into 
the dynamics of stem cells in the mammary gland [1,28], but the translation of these 
findings to the normal human breast is uncertain. In this study, using a combination of 
histological and mitochondrial genetic analysis in human tissues, we obtained evidence 
that the human adult mammary epithelium is maintained by a population of multipotent 
stem cells. Areas containing CCO-deficient cells, which were clonal for mtDNA mutations, 
were found in the normal adult human mammary epithelium and were shown to contain 
cells of both luminal and myoepithelial lineages, thus demonstrating that both mammary 
lineages derive from a long-lived and multipotent progenitor cell. It has been shown 
previously that the accrual of a sufficient burden of somatic mutations which result in CCO-
deficiency may take a considerable period of time (almost 40 years in the human colon) 
[29]. We propose that CCO-deficiency originates in the stem cell population, since these 
are the only long-lived cells within the epithelium. Consequently, the presence of clonal 
CCO-deficient areas in the mammary epithelium that spans both luminal and myoepithelial 
lineages strongly indicates that a pool of multipotential stem cells maintains the adult 
human mammary gland.  
 
Areas containing CCO-deficient cells clonal for mtDNA mutations were also found within 
TDLUs and along lactiferous ducts, suggesting that a dedicated stem cell population may 
not be restricted to a specific compartment of the ductal-lobular system. Previous studies, 
using a variety of putative markers and theoretical models, have proposed that mammary 
gland stem cells are found at the branch points of side-ducts [30], in the ducts [10], or in 
TDLUs, in particular at the edge of growing ductules [11,31]. A more recent study in the 
mouse mammary gland excluded the presence of multipotent progenitor cells, but 
localised unipotent progenitors sporadically in branching ducts or alveoli [32].  
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Our data does not suggest such a restriction between the regions of the ductal-lobular 
system, but indicates that multipotent, dividing stem cells are localized along the whole 
adult mammary epithelium.  Furthermore, the presence of multiple CCO-deficient areas of 
various sizes within the same duct provides an insight into clonal dynamics and clonal 
competition in the normal epithelium. Smaller CCO-deficient areas may represent a new 
clonal expansion or a clone headed towards extinction, whereas larger CCO-deficient 
areas may represent a dominant clone that could eventually lead to a monoclonal 
conversion of the duct, similarly to the process of crypt purification in the human normal 
colon [33]. We observed mainly areas of CCO-deficiency that extended through both 
layers of the mammary duct: however, in two samples we could detect the presence of 
CCO-deficient cells restricted to the luminal layer. This could indicate a differentiation 
hierarchy relating the two ductal lineages, where the progenitor cells are located in the 
luminal layer, expand horizontally within this and only successively derive the 
myoepithelial layer. We could not detect any case where CCO-deficiency was associated 
uniquely to the myoepithelial layer, supporting previous findings which conclude that the 
luminal layer is the location of mammary epithelial progenitor cells [2]. 
 
CCO-deficient clonal areas were also detected in ductal carcinoma in situ (DCIS), 
encompassing partial or entire cross sections. Although we have no data to show directly 
the cell of origin of DCIS, we can propose that DCIS originates from stem cells in the 
luminal layer as it is likely that this is the cell of origin of clonal expansions within the 
breast. We observed larger areas of CCO deficiency in DCIS compared to normal breast: 
if we assume that CCO-deficient cells represent a snapshot in time of the dynamics of the 
stem cells populations within the tissue, our findings would indicate an increase in stem 
cell number in the premalignant lesion.  
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In summary, we have shown that the adult human breast contains a population of stem 
cells localized in the whole ductal-lobular system, which maintain the normal epithelium by 
differentiating into both luminal and myoepithelial cells. This architecture is preserved in 
DCIS but clonal dynamics are altered, and an increase in the size of expanded clones was 
observed within the premalignant lesions compared to the normal breast. 
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FIGURE LEGENDS 
Figure 1. CCO-deficient patches of cells are found through the normal and premalignant 
human breast. (A) H&E staining showing a TDLU in the normal adult breast; (B) CCO 
enzyme histochemistry identifies a subset of cells within the TDLU containing blue, 
CCO−deficient cells. High power images are shown in C and D respectively; CCO-
deficiency is indicated by arrows. CCO-deficient ducts are also found in the ducts of 
normal human breast. (E) H&E staining showing a normal duct from adult human breast; 
(F) CCO enzyme histochemistry identifies three similarly distinct clusters of cells within the 
normal duct containing blue, CCO−deficient cells. High power images are shown in G and 
H respectively.  Scale bar = 150 μm; insert scale bar = 75 μm. (I) and outlined area in (J) 
CCO enzyme histochemistry of a sample of invasive breast cancer with adjacent areas of 
DCIS identifies a large area of CCO-deficient blue cells within the premalignant lesion. 
CCO-deficient cells are interspersed with wild-type CCO-positive brown cells, indicating 
dynamic mixing of clones in DCIS. Scale bar (I) = 2000 μm; insert scale bar (J) = 250 μm. 
I’ and J’ represent globally saturated images (saturation set to 60) to highlight the CCO-
deficient areas in I and J respectively. 
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Figure 2. Clonal expansions occur in both TDLUs and ducts. (A) H&E staining showing a 
TDLU in a normal adult breast and (B) at higher power magnification. (C) CCO enzyme 
histochemistry identifies a discrete TDLU containing blue, CCO−deficient cells and (D) at 
higher magnification. E) Post laser capture microdissection of single cells from multiple 
CCO-deficient blue areas (arrowed in green) together with adjacent CCO-normal brown 
(arrowed in purple, and one cell at greater distance in the section, not shown). Those cells 
without arrows failed to PCR amplify. (F) All CCO-deficient cells shared a common, clonal 
point mutation (3127G>A) that was not present in the control CCO-normal cells. This 
demonstrated clonal expansion within a TDLU. CCO-deficient ducts also show clonal 
expansions. (G) H&E staining showing a normal duct in proximity to DCIS and (H) in 
higher magnification). (I) CCO enzyme histochemistry identifies clusters of blue, 
CCO−deficient cells seen at higher power magnification (J) pre- and (K) post-laser 
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microdissection.  (L) MtDNA sequencing of single cells from multiple blue cells (arrowed in 
K) versus brown wild type cells from a distant area (not shown) demonstrated that two blue 
cells from the larger blue cluster (arrowed in green in K) shared a common, heteroplasmic 
1609T>C mutation that was also present in the single cell laser-captured from a similarly 
distinct area (arrowed in green at the top of the image) but was not present in adjacent 
brown cells or in the other cells laser-captured from distinct blue areas (arrowed in purple). 
These findings showed that normal ducts are clonal and multiple clones compete for the 
monoclonal conversion of the entire duct. Scale bar = 150 μm; insert scale bar = 75 μm. 
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Figure 3. DCIS ducts show multiple, large clonal expansions. (A) H&E staining showing 
adult breast with DCIS ducts. (B) and (Ci-iii) CCO-histochemistry on the serial section 
showing both CCO-deficient (Ci and Cii) and CCO-proficient (Ciii) DCIS ducts.  Areas 1 
and 2 from (Ci) showed a shared 11867_118673insG mutation (shown in the reverse 
sequence strand) that was not detected in area 5 (Ciii). The adjacent CCO-deficient duct 
(Cii areas 3 and 4) did not share the same mutation but was clonal for a heteroplasmic 
957G>A mutation that was also not detected in area 5 (Ciii). Representative Sanger 
sequencing traces are shown below Ci-iii. Scale bar = 600 μm; insert scale bar = 300 μm. 
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Figure 4. Multipotent stem cells reside within clonal CCO-negative normal and DCIS ducts. 
Immunofluorescence staining of serial sections from a normal adult breast (A-D and E-H) 
showed that CCO-negative areas (lacking green CCO expression, F,G) contained cells 
positive for markers of luminal cells (CK18, red) and myoepithelial cells (αSMA, green) (H), 
indicating that multipotential stem cells were present within the CCO-deficient area and 
gave rise to the two differentiated cell types. Similarly, immunofluorescence staining of 
serial sections from a DCIS sample (I-L ; M-P and in higher power magnification, M’-P’) 
showed that CCO-negative areas (N, O and zoomed areas in N’, O’) contained cells 
positive for CK18 and αSMA, green (P and high power P’), that indicated the presence of 
multipotent stem cells within the DCIS duct. Scale bar = 75μm. 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
 
Figure 5. Normal breast contains CCO-deficient patches of cells restricted to the ductal 
luminal layer. (A and C) H&E staining showing two ducts in the normal adult breast; high 
power images in A’ and C’ respectively. (B and D) CCO enzyme histochemistry identified a 
subset of cells within the luminal layer of the ducts containing blue (CCO−deficient) cells. 
High power images in B’ and D’ respectively. Scale bars: A, B = 150 μm; inset scale bar: 
A’, B’ = 75μm. Scale bar of C, D= 300μm; insert scale bar of C’, D’ = 75μm. 
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SUPPLEMENTARY MATERIAL ONLINE 
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Supplementary figure legend  Yes  
 
 
Figure S1. Exclusion of autofluorescent erythrocytes from assessment of lineage tracing 
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